Cargando…

Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study

BACKGROUND: Intravenous glycerol treatment, usually administered in the form of a 5% fructose solution, can be used to reduce intracranial pressure. The administered fructose theoretically influences blood lactate levels, although little is known regarding whether intravenous glycerol treatment caus...

Descripción completa

Detalles Bibliográficos
Autores principales: Katayama, Shinshu, Tonai, Ken, Goto, Yuya, Koyama, Kansuke, Koinuma, Toshitaka, Shima, Jun, Wada, Masahiko, Nunomiya, Shin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114507/
https://www.ncbi.nlm.nih.gov/pubmed/30181880
http://dx.doi.org/10.1186/s40560-018-0323-7
_version_ 1783351205585485824
author Katayama, Shinshu
Tonai, Ken
Goto, Yuya
Koyama, Kansuke
Koinuma, Toshitaka
Shima, Jun
Wada, Masahiko
Nunomiya, Shin
author_facet Katayama, Shinshu
Tonai, Ken
Goto, Yuya
Koyama, Kansuke
Koinuma, Toshitaka
Shima, Jun
Wada, Masahiko
Nunomiya, Shin
author_sort Katayama, Shinshu
collection PubMed
description BACKGROUND: Intravenous glycerol treatment, usually administered in the form of a 5% fructose solution, can be used to reduce intracranial pressure. The administered fructose theoretically influences blood lactate levels, although little is known regarding whether intravenous glycerol treatment causes transient hyperlactatemia. This study aimed to evaluate blood lactate levels in patients who received intravenous glycerol or mannitol. METHODS: This single-center prospective observational study was performed at a 14-bed general intensive care unit between August 2016 and January 2018. Patients were excluded if they were < 20 years old or had pre-existing hyperlactatemia (blood lactate > 2.0 mmol/L). The included patients received intravenous glycerol or mannitol to reduce intracranial pressure and provided blood samples for lactate testing before and after the drug infusion (before the infusion and after 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, and 150 min). RESULTS: Among the 33 included patients, 13 patients received 200 mL of glycerol over 30 min, 13 patients received 200 mL of glycerol over 60 min, and 7 patients received 300 mL of mannitol over 60 min. Both groups of patients who received glycerol had significantly higher lactate levels than the mannitol group (2.8 mmol/L vs. 2.2 mmol/L vs. 1.6 mmol/L, P < 0.0001), with the magnitude of the increase in lactate levels corresponding to the glycerol infusion time. There were no significant inter-group differences in cardiac index, stroke volume, or stroke volume variation. In the group that received the 30-min glycerol infusion, blood lactate levels did not return to the normal range until after 120 min. CONCLUSIONS: Intravenous administration of glycerol leads to higher blood lactate levels that persist for up to 120 min. Although hyperlactatemia is an essential indicator of sepsis and/or impaired tissue perfusion, physicians should be aware of this phenomenon when assessing the blood lactate levels.
format Online
Article
Text
id pubmed-6114507
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-61145072018-09-04 Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study Katayama, Shinshu Tonai, Ken Goto, Yuya Koyama, Kansuke Koinuma, Toshitaka Shima, Jun Wada, Masahiko Nunomiya, Shin J Intensive Care Research BACKGROUND: Intravenous glycerol treatment, usually administered in the form of a 5% fructose solution, can be used to reduce intracranial pressure. The administered fructose theoretically influences blood lactate levels, although little is known regarding whether intravenous glycerol treatment causes transient hyperlactatemia. This study aimed to evaluate blood lactate levels in patients who received intravenous glycerol or mannitol. METHODS: This single-center prospective observational study was performed at a 14-bed general intensive care unit between August 2016 and January 2018. Patients were excluded if they were < 20 years old or had pre-existing hyperlactatemia (blood lactate > 2.0 mmol/L). The included patients received intravenous glycerol or mannitol to reduce intracranial pressure and provided blood samples for lactate testing before and after the drug infusion (before the infusion and after 15 min, 30 min, 45 min, 60 min, 90 min, 120 min, and 150 min). RESULTS: Among the 33 included patients, 13 patients received 200 mL of glycerol over 30 min, 13 patients received 200 mL of glycerol over 60 min, and 7 patients received 300 mL of mannitol over 60 min. Both groups of patients who received glycerol had significantly higher lactate levels than the mannitol group (2.8 mmol/L vs. 2.2 mmol/L vs. 1.6 mmol/L, P < 0.0001), with the magnitude of the increase in lactate levels corresponding to the glycerol infusion time. There were no significant inter-group differences in cardiac index, stroke volume, or stroke volume variation. In the group that received the 30-min glycerol infusion, blood lactate levels did not return to the normal range until after 120 min. CONCLUSIONS: Intravenous administration of glycerol leads to higher blood lactate levels that persist for up to 120 min. Although hyperlactatemia is an essential indicator of sepsis and/or impaired tissue perfusion, physicians should be aware of this phenomenon when assessing the blood lactate levels. BioMed Central 2018-08-28 /pmc/articles/PMC6114507/ /pubmed/30181880 http://dx.doi.org/10.1186/s40560-018-0323-7 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Katayama, Shinshu
Tonai, Ken
Goto, Yuya
Koyama, Kansuke
Koinuma, Toshitaka
Shima, Jun
Wada, Masahiko
Nunomiya, Shin
Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study
title Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study
title_full Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study
title_fullStr Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study
title_full_unstemmed Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study
title_short Transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study
title_sort transient hyperlactatemia during intravenous administration of glycerol: a prospective observational study
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6114507/
https://www.ncbi.nlm.nih.gov/pubmed/30181880
http://dx.doi.org/10.1186/s40560-018-0323-7
work_keys_str_mv AT katayamashinshu transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy
AT tonaiken transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy
AT gotoyuya transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy
AT koyamakansuke transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy
AT koinumatoshitaka transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy
AT shimajun transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy
AT wadamasahiko transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy
AT nunomiyashin transienthyperlactatemiaduringintravenousadministrationofglycerolaprospectiveobservationalstudy